During the past decade, Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored and "City of Hope Medical Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "US Oncology Research" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" are "Breast Cancer" (8 trials), "Breast Neoplasm" (1 trials), "Lung Cancer" (1 trials), "Metastatic Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" are "Drug" (8 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (2 trials), "cyclophosphamide" (2 trials), "docetaxel" (2 trials), "pegfilgrastim" (2 trials) and ""Investigator's Choice" chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center" are 6 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".